171 related articles for article (PubMed ID: 26788726)
1. Efficacy of Adjuvant Chemotherapy and Prognostic Factors for Patients with Extrahepatic Bile Duct Cancer.
Lee HS; Lee SH; Roh YH; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
Chemotherapy; 2016; 61(3):152-8. PubMed ID: 26788726
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Prognostic Factors and the Efficacy of Adjuvant S-1 Chemotherapy in Patients with Post-surgery Extrahepatic Bile Duct Cancer.
Okabayashi T; Shima Y; Iwata J; Morita S; Sumiyoshi T; Sui K; Shimada Y; Iiyama T
Anticancer Res; 2017 Dec; 37(12):7049-7056. PubMed ID: 29187494
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
[TBL] [Abstract][Full Text] [Related]
4. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection.
Jang JY; Kim SW; Park DJ; Ahn YJ; Yoon YS; Choi MG; Suh KS; Lee KU; Park YH
Ann Surg; 2005 Jan; 241(1):77-84. PubMed ID: 15621994
[TBL] [Abstract][Full Text] [Related]
5. Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):81-7. PubMed ID: 22789492
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer.
Kim TH; Han SS; Park SJ; Lee WJ; Woo SM; Moon SH; Yoo T; Kim SS; Kim SH; Hong EK; Kim DY; Park JW
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e853-9. PubMed ID: 21497455
[TBL] [Abstract][Full Text] [Related]
7. Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy.
Gwak HK; Kim WC; Kim HJ; Park JH
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):194-8. PubMed ID: 19910130
[TBL] [Abstract][Full Text] [Related]
8. Impact of adjuvant radiation therapy for microscopic residual tumor after resection of extrahepatic bile duct cancer.
Matsuda T; Fujita H; Harada N; Kunimoto Y; Tanaka T; Kimura T; Kitaoka H; Asano E; Hosono M; Hayashi T; Ogino K
Am J Clin Oncol; 2013 Oct; 36(5):461-5. PubMed ID: 22706178
[TBL] [Abstract][Full Text] [Related]
9. [Long-term results of 84 surgically treated patients with extrahepatic bile duct carcinoma].
Zheng SS; Qin YS; Liang TB; Huang DS; Zhang M; Wang WL; Shen Y; Wang JH
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):554-6. PubMed ID: 16438856
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct.
Alden ME; Waterman FM; Topham AK; Barbot DJ; Shapiro MJ; Mohiuddin M
Radiology; 1995 Nov; 197(2):511-6. PubMed ID: 7480704
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer.
Kato Y; Takahashi S; Gotohda N; Konishi M
J Gastrointest Surg; 2016 Aug; 20(8):1435-43. PubMed ID: 27250990
[TBL] [Abstract][Full Text] [Related]
12. High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients.
Park Y; Kim K; Paik JH; Chie EK; Jang JY; Kim SW; Oh DY
Eur J Surg Oncol; 2018 May; 44(5):638-643. PubMed ID: 29422250
[TBL] [Abstract][Full Text] [Related]
13. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
[TBL] [Abstract][Full Text] [Related]
14. Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Nakagawa N; Muto T; Sasaki H; Urabe K; Sueda T
J Gastrointest Surg; 2013 Aug; 17(8):1429-39. PubMed ID: 23797881
[TBL] [Abstract][Full Text] [Related]
15. Postoperative chemoradiotherapy for extrahepatic bile duct cancer.
Park JH; Choi EK; Ahn SD; Lee SW; Song SY; Yoon SM; Kim YS; Lee YS; Lee SG; Hwang S; Lee YJ; Park KM; Kim TW; Chang HM; Lee JL; Kim JH
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):696-704. PubMed ID: 20510541
[TBL] [Abstract][Full Text] [Related]
16. The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer.
Kim MW; Kim WH; Wang HJ; Chung JB; Chun M
Hepatogastroenterology; 2001; 48(41):1298-301. PubMed ID: 11677950
[TBL] [Abstract][Full Text] [Related]
17. Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?
Park HJ; Kim K; Paik JH; Chie EK; Kim S; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Clin Transl Oncol; 2016 Jun; 18(6):625-31. PubMed ID: 26459257
[TBL] [Abstract][Full Text] [Related]
18. CD24 expression predicts distant metastasis in extrahepatic bile duct cancer.
Kim K; Min HS; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Jang JJ; Ha SW
World J Gastroenterol; 2013 Mar; 19(9):1438-43. PubMed ID: 23539485
[TBL] [Abstract][Full Text] [Related]
19. Patterns of failure after resection of extrahepatic bile duct cancer: implications for adjuvant radiotherapy indication and treatment volumes.
Choi HS; Kang KM; Jeong BK; Jeong H; Lee YH; Ha IB; Kim TG; Song JH
Radiat Oncol; 2018 May; 13(1):85. PubMed ID: 29739420
[TBL] [Abstract][Full Text] [Related]
20. Carcinoma of the extrahepatic bile duct: mode of spread and its prognostic implications.
Yamaguchi K; Chijiiwa K; Saiki S; Shimizu S; Takashima M; Tanaka M
Hepatogastroenterology; 1997; 44(17):1256-61. PubMed ID: 9356836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
